vs
Side-by-side financial comparison of BADGER METER INC (BMI) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $234.1M, roughly 1.4× BADGER METER INC). BADGER METER INC runs the higher net margin — 14.3% vs 4.0%, a 10.3% gap on every dollar of revenue. On growth, BADGER METER INC posted the faster year-over-year revenue change (14.1% vs 2.2%).
Badger Meter Inc. is a leading global provider of flow measurement and control solutions, serving water utilities, industrial, commercial, and residential customer segments. Its core offerings include smart water meters, IoT-enabled usage monitoring systems, and supporting software that help clients track resource consumption, cut waste, and boost operational efficiency, with key markets spanning North America, Europe, and the Asia-Pacific region.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
BMI vs GRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $234.1M | $336.6M |
| Net Profit | $33.6M | $13.5M |
| Gross Margin | 39.7% | 22.7% |
| Operating Margin | 18.4% | 5.3% |
| Net Margin | 14.3% | 4.0% |
| Revenue YoY | 14.1% | 2.2% |
| Net Profit YoY | 9.3% | 46.1% |
| EPS (diluted) | $1.13 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $336.6M | ||
| Q4 25 | $234.1M | $397.6M | ||
| Q3 25 | $222.2M | $377.4M | ||
| Q2 25 | $238.1M | $344.3M | ||
| Q1 25 | $222.2M | $329.3M | ||
| Q4 24 | $205.2M | — | ||
| Q3 24 | $208.4M | $314.4M | ||
| Q2 24 | $216.7M | — |
| Q1 26 | — | $13.5M | ||
| Q4 25 | $33.6M | $20.9M | ||
| Q3 25 | $35.1M | $9.8M | ||
| Q2 25 | $34.6M | $9.0M | ||
| Q1 25 | $38.4M | $9.4M | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $32.0M | $-122.0M | ||
| Q2 24 | $33.1M | — |
| Q1 26 | — | 22.7% | ||
| Q4 25 | 39.7% | 21.5% | ||
| Q3 25 | 43.1% | 19.8% | ||
| Q2 25 | 41.1% | 19.8% | ||
| Q1 25 | 42.9% | 19.5% | ||
| Q4 24 | 40.3% | — | ||
| Q3 24 | 40.2% | 19.4% | ||
| Q2 24 | 39.4% | — |
| Q1 26 | — | 5.3% | ||
| Q4 25 | 18.4% | 7.7% | ||
| Q3 25 | 20.7% | 4.3% | ||
| Q2 25 | 18.8% | 3.7% | ||
| Q1 25 | 22.2% | 3.9% | ||
| Q4 24 | 19.1% | — | ||
| Q3 24 | 19.5% | -33.3% | ||
| Q2 24 | 19.2% | — |
| Q1 26 | — | 4.0% | ||
| Q4 25 | 14.3% | 5.3% | ||
| Q3 25 | 15.8% | 2.6% | ||
| Q2 25 | 14.5% | 2.6% | ||
| Q1 25 | 17.3% | 2.9% | ||
| Q4 24 | 15.0% | — | ||
| Q3 24 | 15.4% | -38.8% | ||
| Q2 24 | 15.3% | — |
| Q1 26 | — | $0.21 | ||
| Q4 25 | $1.13 | — | ||
| Q3 25 | $1.19 | — | ||
| Q2 25 | $1.17 | — | ||
| Q1 25 | $1.30 | — | ||
| Q4 24 | $1.04 | — | ||
| Q3 24 | $1.08 | — | ||
| Q2 24 | $1.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $64.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $713.3M | $232.4M |
| Total Assets | $973.6M | $426.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.9M | ||
| Q4 25 | — | $65.6M | ||
| Q3 25 | — | $36.5M | ||
| Q2 25 | — | $18.8M | ||
| Q1 25 | — | $14.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $0 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $34.3M | ||
| Q2 24 | — | — |
| Q1 26 | — | $232.4M | ||
| Q4 25 | $713.3M | $217.9M | ||
| Q3 25 | $702.5M | $195.5M | ||
| Q2 25 | $677.6M | $179.7M | ||
| Q1 25 | $641.7M | $163.2M | ||
| Q4 24 | $606.2M | — | ||
| Q3 24 | $591.2M | $133.9M | ||
| Q2 24 | $563.1M | — |
| Q1 26 | — | $426.9M | ||
| Q4 25 | $973.6M | $412.7M | ||
| Q3 25 | $978.3M | $390.0M | ||
| Q2 25 | $936.4M | $356.3M | ||
| Q1 25 | $899.6M | $334.0M | ||
| Q4 24 | $816.4M | — | ||
| Q3 24 | $802.9M | $348.0M | ||
| Q2 24 | $781.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $54.8M | $6.1M |
| Free Cash FlowOCF − Capex | $50.8M | — |
| FCF MarginFCF / Revenue | 21.7% | — |
| Capex IntensityCapex / Revenue | 1.7% | — |
| Cash ConversionOCF / Net Profit | 1.63× | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | $169.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $6.1M | ||
| Q4 25 | $54.8M | $34.6M | ||
| Q3 25 | $51.3M | $28.2M | ||
| Q2 25 | $44.6M | $19.9M | ||
| Q1 25 | $33.0M | $17.6M | ||
| Q4 24 | $52.1M | — | ||
| Q3 24 | $45.1M | — | ||
| Q2 24 | $36.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $50.8M | — | ||
| Q3 25 | $48.2M | $24.2M | ||
| Q2 25 | $40.6M | — | ||
| Q1 25 | $30.1M | — | ||
| Q4 24 | $47.4M | — | ||
| Q3 24 | $42.0M | — | ||
| Q2 24 | $34.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 21.7% | — | ||
| Q3 25 | 21.7% | 6.4% | ||
| Q2 25 | 17.1% | — | ||
| Q1 25 | 13.5% | — | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | 20.1% | — | ||
| Q2 24 | 15.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.7% | — | ||
| Q3 25 | 1.4% | 1.1% | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.1% | — |
| Q1 26 | — | 0.45× | ||
| Q4 25 | 1.63× | 1.65× | ||
| Q3 25 | 1.46× | 2.87× | ||
| Q2 25 | 1.29× | 2.21× | ||
| Q1 25 | 0.86× | 1.86× | ||
| Q4 24 | 1.70× | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BMI
| Transferred At Point In Time | $198.6M | 85% |
| Transferred Over Time | $22.1M | 9% |
| Other | $13.4M | 6% |
GRDN
Segment breakdown not available.
